Silvana Saracchini
Impact in
-
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 17
- Cancer Treatment and Pharmacology 11
- HER2/EGFR in Cancer Research 5
- Colorectal Cancer Treatments and Studies 4
-
- Breast Cancer Treatment Studies 10
- Co-authors
- Diana Crivellari (5 shared papers)Enzo Galligioni (4 shared papers)S. Monfardini (5 shared papers)Massimo Gion (5 shared papers)Roberto Sorio (3 shared papers)I. Robieux (1 shared paper)Andrea Freschi (2 shared papers)Giulio Vignati (4 shared papers)
In The Last Decade
Silvana Saracchini
29 papers receiving 332 citations
Peers
Comparison fields: 5 of 58
- Oncology 186
- Cancer Research 92
- Pulmonary and Respiratory Medicine 50
- Pathology and Forensic Medicine 22
- Radiology, Nuclear Medicine and Imaging 28
Countries citing papers authored by Silvana Saracchini
This map shows the geographic impact of Silvana Saracchini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvana Saracchini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvana Saracchini more than expected).
Fields of papers citing papers by Silvana Saracchini
This network shows the impact of papers produced by Silvana Saracchini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvana Saracchini. The network helps show where Silvana Saracchini may publish in the future.
Co-authors
The 25 scholars most cited alongside Silvana Saracchini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 59 | |
| 2 | 2011 | 41 | |
| 3 | 2015 | 40 | |
| 4 | 1996 | 35 | |
| 5 | 1995 | 23 | |
| 6 | 2011 | 20 | |
| 7 | 2013 | 19 | |
| 8 | 2005 | 14 | |
| 9 | 1998 | 12 | |
| 10 | 2013 | 11 | |
| 11 | 1993 | 11 | |
| 12 | 1994 | 9 | |
| 13 | 2015 | 9 | |
| 14 | Tumor markers in breast cancer monitoring should be scheduled according to initial stage and follow-up time: a prospective study on 859 patients. | 2001 | 8 |
| 15 | Comparison of presenting clinical and laboratory findings of patients with persistent generalized lymphadenopathy (PGL) syndrome and malignant lymphoma (ML). | 1988 | 8 |
| 16 | 1991 | 6 | |
| 17 | 1989 | 2 | |
| 18 | 2014 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 1986 | 2 |
About Silvana Saracchini
Silvana Saracchini is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 32 papers that have together received 343 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (11 papers), Breast Cancer Treatment Studies (10 papers), HER2/EGFR in Cancer Research (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers), Advanced Breast Cancer Therapies (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Lymphadenopathy Diagnosis and Analysis (2 papers). The work is most often cited by research in Oncology (186 citations), Cancer Research (92 citations), Pulmonary and Respiratory Medicine (50 citations), Pathology and Forensic Medicine (22 citations) and Radiology, Nuclear Medicine and Imaging (28 citations). Silvana Saracchini has collaborated with scholars based in Italy, Germany and Spain. Frequent co-authors include Diana Crivellari, Enzo Galligioni, S. Monfardini, Massimo Gion, Roberto Sorio, I. Robieux, Andrea Freschi, Giulio Vignati, R. Mione and Alessandro Del Conte. Their work appears in journals such as The Breast, Journal of Clinical Oncology, Cancer Research, European Journal of Cancer and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.